Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems

Ghassan Tashkandi; Alexey Goltsov; Peter Mullen; James Bown; David Harrison; Simon Langdon

doi:10.1158/1538-8514.PI3K14-B33

Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems

Ghassan Tashkandi, Alexey Goltsov, Peter Mullen, James Bown, David Harrison, Simon Langdon

Research output: Contribution to journal › Meeting Abstract

Original language	English
Pages (from-to)	B33
Number of pages	1
Journal	Molecular Cancer Therapeutics
Volume	14
Issue number	7, Suppl.
DOIs	https://doi.org/10.1158/1538-8514.PI3K14-B33
Publication status	Published - Jul 2015
Event	American Association for Cancer Research Special Conference: Targeting he PI3K-mTOR Network in Cancer - Philadelphia, United States Duration: 14 Sep 2014 → 17 Sep 2014

Access to Document

10.1158/1538-8514.PI3K14-B33

Cite this

@article{d13feb66bd484dd0b08b3030d8fd1032,

title = "Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems",

author = "Ghassan Tashkandi and Alexey Goltsov and Peter Mullen and James Bown and David Harrison and Simon Langdon",

year = "2015",

month = jul,

doi = "10.1158/1538-8514.PI3K14-B33",

language = "English",

volume = "14",

pages = "B33",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "7, Suppl.",

note = "American Association for Cancer Research Special Conference : Targeting he PI3K-mTOR Network in Cancer, AACR ; Conference date: 14-09-2014 Through 17-09-2014",

}

TY - JOUR

T1 - Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems

AU - Tashkandi, Ghassan

AU - Goltsov, Alexey

AU - Mullen, Peter

AU - Bown, James

AU - Harrison, David

AU - Langdon, Simon

PY - 2015/7

Y1 - 2015/7

U2 - 10.1158/1538-8514.PI3K14-B33

DO - 10.1158/1538-8514.PI3K14-B33

M3 - Meeting Abstract

VL - 14

SP - B33

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 7, Suppl.

T2 - American Association for Cancer Research Special Conference

Y2 - 14 September 2014 through 17 September 2014

ER -